CMED in the treatment of nasal natural killer cell lymphoma with distant metastases

Hematology

Volumn 12, Issue 3, 2007, Pages 241-244

  Avilés, Agustin ^a   Cleto, Sergio ^a   Castañeda, Claudia ^a   Nambo, Maria Jesés ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Malignant lymphoma; Nasal lymphoma; Natural killer cell lymphoma; RFS

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; LACTATE DEHYDROGENASE; METHOTREXATE;

ADULT; ALOPECIA; ARTICLE; BLOOD TOXICITY; BONE MARROW METASTASIS; BONE METASTASIS; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG FATALITY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HIGH RISK PATIENT; HUMAN; INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG METASTASIS; LYMPHADENOPATHY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL LYMPHOMA; NOSE CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SHORT COURSE THERAPY; SKIN METASTASIS; STOMACH DISEASE; TESTIS DISEASE; THROMBOCYTOPENIA; TREATMENT FAILURE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; FEMALE; HUMANS; KILLER CELLS, NATURAL; LEUCOVORIN; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM METASTASIS; NOSE NEOPLASMS; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34250659715     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330701214327     Document Type: Article

References (15)

1. Au, WY, Ma, SY, Chim, CS, Choy, S., Luong, F. and Lie, KW (2005) Clinico-pahtological features and treatment outcome of mature T-cell and natural/killer cell lymphoma according to the World Health Organization Classification scheme. Ann Oncol, 16, pp. 206-214.
2. Lee, J., Suh, C., Park, YH, Ko, YH, Bang, SM and Lee, JH (2006) Extra nodal natural killer T cell lymphoma nasal type. A prognostic model from a retrospective multicenter study. J Clin Oncol, 24, pp. 612-618.
3. Avilés, A., Diaz, NR, Neri, N., Cleto, S. and Talavera, A. (2000) Angiocentric nasal T/natural killer cell lymphoma. A single centre study of prognostic factors in 108 patients. Clin Lab Haematol, 22, pp. 215-220.
4. Kim, BS, Kim, TY, Kim, CW, Kim, JY and Heo, DS (2003) Therapeutic outcome of extranodal NK/T cell lymphoma initially treated with chemotherapy. Acta Oncol, 43, pp. 779-783.
5. Chim, CS, Ma, SY, Au, WY, Choy, C., Lie, AKW and Liang, R. (2004) Primary nasal natural killer cell lymphoma. Long term treatment outcome and relationship with the international prognostic index. Blood, 103, pp. 216-221.
6. Kim, GE, Cho, JH, Yang, WY, Chung, EJ, Chang, O. and Park, KR (2000) Angiocentric lymphoma of the head and neck. Patterns of failure after radiation treatment. J Clin Oncol, 18, pp. 54-62.
7. Li, YX, Yao, B., Jin, J., Wang, WH, Liu, YP and Song, YW (2006) Radiotherapy as primary treatment for stage IE and IIE nasal natural killer T-cell lymphoma. J Clin Oncol, 24, pp. 181-189.
8. Kwong, Y. (2005) Natural killer cell malignancies. Diagnosis and treatment. Leukemia, 19, pp. 2186-2194.
9. Kwong, YL, Chan, ACCL, Liang, R., Chiang, AKW, Chim, CS and Chan, TK (1997) CD 56+ NK lymphomas. Clinico-pathological features and prognosis. Br J Haematol, 97, pp. 821-829.
10. Loni, L., Tacca, M Del and Danesi, R. (2001) Pharmacogenetics of anticancer drugs in non-Hodgkin's lymphoma. Br J Cancer, 85, pp. 1425-1431.
11. Avilés, A., Delgado, S., Fernandez, A., Nambo, MJ and Rosas, A. (1994) Combined therapy for angioimmunoproliferative lesions. Oral Oncol Eur J Cancer, 30, pp. 302-304.
12. Rüdiger, T., Weisenburger, DD and Anderson, JR (2002) Peripheral T-cell lymphoma (excluding anaplastic large cell lymphoma). Results for the non-Hodgkin's classification project. Ann Oncol, 13, pp. 140-149.
13. Au, WY, Lie, AKW, Liang, R., Kwong, YL, Yau, CL and Cheung, MMC (2003) Autologous stem cell transplantation for nasal NK/T cell lymphoma. Ann Oncol, 14, pp. 673-676.
14. Kim, JS, Kim, BS and Choi, CW (2006) Treatment outcome of front line systemic chemotherapy for localized extranodal NK/cell lymphoma in nasal and upper aerodigestive tract. Leuk Lymphoma, 47, pp. 1265-1273.
15. Lee, KW, Yun, T. and Kim, DW (2006) First line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy+radiotherapy is active in patients with stage I/II extranodal NK/T cell lymphoma. Leuk Lymphoma, 47, pp. 1274-1282.